(MedPage Today) -- Greater risk reduction in most PFO-likely strokes, younger age group
via TCT: Final Amplatzer Data Still Support Narrow Use
by
Wednesday, November 2, 2016
Tuesday, November 1, 2016
TCT: Good Safety, Effiacy With Novel Drug-Filled Stent
(MedPage Today) -- Will this be the device that finally brings DAPT down to 1 month?
via TCT: Good Safety, Effiacy With Novel Drug-Filled Stent
by
via TCT: Good Safety, Effiacy With Novel Drug-Filled Stent
by
HFSA: Can a Biomarker Explain the PARADIGM Findings? (CME/CE)
(MedPage Today) -- A biomarker 1,000 pound gorilla
via HFSA: Can a Biomarker Explain the PARADIGM Findings? (CME/CE)
by
via HFSA: Can a Biomarker Explain the PARADIGM Findings? (CME/CE)
by
TCT: Second Generation Approaching for Absorbable Stents
(MedPage Today) -- The race is on for thinner, faster, safer devices
via TCT: Second Generation Approaching for Absorbable Stents
by
via TCT: Second Generation Approaching for Absorbable Stents
by
TCT: Embolic Protection Flops for TAVR
(MedPage Today) -- New brain lesions or clinical strokes unaffected in SENTINEL trial
via TCT: Embolic Protection Flops for TAVR
by
via TCT: Embolic Protection Flops for TAVR
by
Morning Break: PCSK9 Drug Dropped; Zika and Fertility; Medical MJ in Court
(MedPage Today) -- Health news and commentary from around the Web, gathered by the MedPage Today staff
via Morning Break: PCSK9 Drug Dropped; Zika and Fertility; Medical MJ in Court
by
via Morning Break: PCSK9 Drug Dropped; Zika and Fertility; Medical MJ in Court
by
TCT: Steady-Release DES Matches Resolute Shorter-Term
(MedPage Today) -- Target-lesion failure results were even in registration trial
via TCT: Steady-Release DES Matches Resolute Shorter-Term
by
via TCT: Steady-Release DES Matches Resolute Shorter-Term
by
Subscribe to:
Posts (Atom)